Electroceuticals / Bioelectric Medicine Market
Electroceuticals / Bioelectric Medicine Market Analysis By Product Type (Cardiac Pacemakers & ICDs, Cochlear Implants, Spinal Cord Stimulators, Deep Brain Stimulators & Others) By End-User and By Region – Global Market Insights 2022 to 2026
Analysis of Electroceuticals / Bioelectric Medicine market covering 30 + countries including analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
Electroceuticals / Bioelectric Medicine Market Outlook (2022 to 2026)
The global electroceuticals / bioelectric medicine market is valued at US$ 24.5 billion and is projected to attain a revenue of US$ 32.1 billion by the end of 2026. This Fact.MR survey predicts worldwide demand for electroceuticals / bioelectric medicines to increase rapidly at a CAGR of 6.9% over the next four years.
Advancements in the medical industry have picked up pace over the past few years and have revolutionized medicine and treatments, which has subsequently driven the growth of the electroceuticals / bioelectric medicine market.
| Report Attributes | Details |
|---|---|
Report Attributes |
Details |
| Electroceuticals / Bioelectric Medicine Market Size (2022) | US$ 24.5 Billion |
| Projected Market Value (2026F) | US$ 32.1 Billion |
| Global Market Growth Rate (2022 to 2026) | 6.9% CAGR |
| North America Market Share (2022) | 30% |
| Key Companies Profiled | Sonova Holding AG; LivaNova PLC; Soterix Medical Inc.; NeuroPace Inc.; Stimwave LLC; Vomaris Innovations Inc.; Nevro Corporation; Biotronik; Second Sight Medical Products Inc.; Oticon Medical; Boston Scientific Corporation; St. Jude Medical; GiMer Medical; Cochlear Limited; ElectroCore LLC; BioElectronics Corporation; MED-EL; Set Point Medical; Cefaly Technology; Medtronic plc.; EnteroMedics Inc.; BioWave Corporation; NeuroSigma Inc. |
Don't Need a Global Report?
save 40%! on Country & Region specific reports
Revenue Analysis of Electroceuticals / Bioelectric Medicines (2017 to 2021) in Comparison to Market Growth Forecasts (2022 to 2026)
Rapid advancements in the healthcare industry and increasing proliferation of technology in medical applications are expected to fuel electroceuticals / bioelectric medicine market growth across the forecast period.
Sales of bioelectric medicines and electroceuticals are projected to increase at a brisk pace at a CAGR of 6.9% from 2022 to 2026.
Increasing investments in the R&D sector, growing aging population, high incidence of chronic diseases, rapid advances in medical technology, and growing awareness and acceptance of alternative medicine are prime factors that are predicted to positively impact market growth over the next four years.
Rising popularity of minimally-invasive procedures is expected to result in higher demand for non-invasive electroceutical devices than implantable electroceutical devices.
However, stringent regulatory norms, frequent product recalls, longer time for approvals, and high costs are expected to be the key prospects that could constrain electroceuticals / bioelectric medicine market potential throughout the forecast period.
What’s Driving Electroceuticals / Bioelectric Medicine Market Potential?
“Rising Incidence of Cardiovascular Illnesses across Regions”
The world has witnessed a notable increase in the prevalence of cardiovascular disorders and this is expected to favor electroceuticals / bioelectric medicine market growth across the forecast period.
Electroceuticals and bioelectric medicines are being used in the treatment of several cardiovascular disorders and this trend is anticipated to be rife over the next few years. Implantable cardioverter defibrillators are expected to witness high demand through 2026.
“Increasing Investments in Research & Development”
Focus on healthcare has bolstered over the past couple of decades owing to the emergence of chronic and infectious diseases across the world. This has subsequently led to an increased demand for new treatments and is driving the demand for more research and development in the healthcare industry.
Governments are launching supportive initiatives and funding to advance research and development and this is expected to favor electroceuticals / bioelectric medicine market potential over the next four years.
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
What’s Dwarfing Electroceutical / Bioelectric Medicine Sales?
“Stringent Regulatory Mandates by Various Organizations”
Governments across the world have been implementing strict norms for the development and manufacturing of medical devices and other medical products to ensure patient safety.
This creates a major challenge for electroceutical and bioelectric medicine manufacturers and acts as a restraining factor for the overall electroceuticals / bioelectric medicine market growth throughout the forecast period.
“Product Recalls & High Cost of Development”
Electroceuticals and bioelectric medicines need to undergo rigorous testing through clinical trials to be approved by regulatory authorities and commercialized further. This clinical testing increases the overall development costs and hence results in an expensive product which potentially slows down the overall market revenue generation.
Frequent product recalls owing to long-term side effects and improper operation are becoming a common trend in the market and are expected to hinder electroceutical / bioelectric medicine demand over the coming years.
How Can Aspiring Market Players Make a Mark in This Marketplace?
“Start-ups Can Leverage Use of Technology to Develop Novel Products”
Upcoming market players are anticipated to focus on the innovation and integration of advanced technologies to create novel electroceuticals / bioelectric medications.
- Theranica, a company focused on developing advanced digital therapeutics, founded in 2016, developed a novel therapeutic electroceutical device that helps in addressing migraine pain. Nerivio is cleared by the FDA for the treatment of episodic and chronic migraine and is a wearable device that can be controlled via a smartphone.
- A digital health start-up based in Israel, Healables, is focusing on developing home-based electroceutical treatment. The device developed by the start-up delivers electrotherapy for the legs and arms. The company is developing two models, of which, one is for athletes and the other would be a medical model available through prescription.
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
Which Region Should Electroceutical / Bioelectric Medicine Companies Target?
“North America & Europe to Be Leading Regional Markets”
The market for electroceuticals / bioelectric medicines in North America currently accounts for a dominant market share and is expected to maintain a similar stance throughout the forecast period.
Market growth in this region can be attributed to the presence of key market players such as Medtronic, Abbott, and Boston Scientific, along with high investments in the research and development sector. The United States and Canada are projected to be the prime markets in this region over the next four years.
The Europe electroceuticals / bioelectric medicine market is expected to exhibit lucrative opportunities owing to its rising geriatric population and increasing investments in healthcare infrastructure development. Prevalence of chronic diseases and adoption of novel medical technologies are also anticipated to attract electroceutical / bioelectric medicine manufacturers toward this region through 2026.
A detailed and comprehensive regional assessment has been provided in this latest electroceuticals / bioelectric medicine market study by analysts at Fact.MR, a market research and competitive intelligence provider.
Country-wise Insights
How Investment-worthy is the U.S. Market?
“High Spending on Research Providing Rewarding Business Opportunities”
The United States electroceuticals / bioelectric medicine market is anticipated to emerge as a highly lucrative market for key companies as well as aspiring startups owing to its developed healthcare infrastructure and rapid adoption of novel technologies.
High spending on research and development activities in the country is also expected to propel electroceutical and bioelectric medicine sales in the country through 2026. Supportive government initiatives are projected to further bolster electroceutical / bioelectric medicine demand.
Demand for advanced bioelectric medicines for treatments in the United States is expected to be governed by factors such as the growing geriatric population, rising incidence of cardiovascular disorders, and high healthcare expenditure.
Category-wise Insights
Which Product Type is Anticipated to Lead Revenue Generation?
“Cardiac Pacemakers & ICDs to Drive Global Electroceutical / Bioelectric Medicine Demand”
The global electroceuticals / bioelectric medicine market based on product type is segmented into cardiac pacemakers & ICDs, cochlear implants, spinal cord stimulators, deep brain stimulators, and other product types.
The cardiac pacemakers and ICDs segment is anticipated to account for a dominant market share throughout the forecast period owing to the rising incidence of cardiovascular disorders across the world.
The growth of the geriatric population which is more prone to cardiac diseases is also expected to supplement the demand for cardiac pacemakers and ICDs over the next four years. The growing aging population is also expected to drive demand for cochlear implants over the forecast period.
An increasing number of accidents and rising trauma cases are projected to favor demand for spinal cord stimulators. The high prevalence of neurological disorders and advancements in neurological therapies and treatments are anticipated to positively influence the growth of the deep brain stimulators segment over the years to come.
Competitive Landscape
Suppliers of bioelectric medicines and electroceuticals are expected to adopt various strategies to strengthen their R&D capabilities to fast-track the launch of novel products and increase their market presence.
- In May 2021, Micron Medical, a private medical device company specializing in the development and manufacturing of minimally-invasive electroceutical devices, announced the sale of its pain nerve stimulator franchise to Pain Specialists Group Ltd. Moventis PNS is an implantable and drug-free pain nerve stimulator approved by the FDA in 2020.
Collaborations, partnerships, mergers, and acquisitions are expected to be popular among bioelectric medicine manufacturers and electroceutical companies over the coming years.
- In June 2021, NeuroSigma, a company focused on the development and commercialization of trigeminal nerve stimulation (TNS), partnered with KT, a leading telecom giant in South Korea. This partnership was aimed at promoting the commercialization and development of a new electroceutical based on eTNS.
- In January 2020, Medtronic, a leading medical device manufacturer, announced the acquisition of Stimgenics, an organization that pioneered a novel spinal cord stimulation. The acquisition was aimed at expanding Medtronic’s pain therapies business division.
Electroceuticals / Bioelectric Medicine Industry Research Segmentations
-
By Product Type :
- Cardiac Pacemakers & ICDs
- Cochlear Implants
- Spinal Cord Stimulators
- Deep Brain Stimulators
- Other Product Types
-
By End User :
- Hospitals
- Clinics
- Ambulatory Surgical Centers
- Other End Users
-
By Region :
- North America
- Latin America
- Europe
- APAC
- MEA
Table of Content
- 1. Executive Summary
- 2. Market Overview
- 3. Key Market Trends
- 4. Key Success Factors
- 5. Market Background
- 6. Global Market Volume (Units) Analysis 2017 to 2021 and Forecast, 2022 to 2026
- 7. Global Market - Pricing Analysis
- 8. Global Market Value Analysis 2017 to 2021 and Forecast, 2022 to 2026
- 9. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2026, by Product Type
- 9.1. Cardiac Pacemakers & ICDs
- 9.2. Cochlear Implants
- 9.3. Spinal Cord Stimulators
- 9.4. Deep Brain Stimulators
- 9.5. Other Product Types
- 10. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2026, by End User
- 10.1. Hospitals
- 10.2. Clinics
- 10.3. Ambulatory Surgical Centers
- 10.4. Other End Users
- 11. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2026, by Region
- 11.1. North America
- 11.2. Latin America
- 11.3. Europe
- 11.4. East Asia
- 11.5. South Asia
- 11.6. Oceania
- 11.7. Middle East and Africa (MEA)
- 12. North America Market Analysis 2017 to 2021 and Forecast 2022 to 2026
- 13. Latin America Market Analysis 2017 to 2021 and Forecast 2022 to 2026
- 14. Europe Market Analysis 2017 to 2021 and Forecast 2022 to 2026
- 15. South Asia Market Analysis 2017 to 2021 and Forecast 2022 to 2026
- 16. East Asia Market Analysis 2017 to 2021 and Forecast 2022 to 2026
- 17. Oceania Market Analysis 2017 to 2021 and Forecast 2022 to 2026
- 18. Middle East and Africa Market Analysis 2017 to 2021 and Forecast 2022 to 2026
- 19. Key and Emerging Countries Market Analysis 2017 to 2021 and Forecast 2022 to 2026
- 20. Market Structure Analysis
- 21. Competition Analysis
- 21.1. Sonova Holding AG
- 21.2. LivaNova PLC
- 21.3. Soterix Medical Inc.
- 21.4. NeuroPace Inc.
- 21.5. Stimwave LLC
- 21.6. Vomaris Innovations Inc.
- 21.7. Nevro Corporation
- 21.8. Biotronik
- 21.9. Second Sight Medical Products Inc.
- 21.10. Oticon Medical
- 21.11. Boston Scientific Corporation
- 21.12. St. Jude Medical
- 21.13. GiMer Medical
- 21.14. Cochlear Limited
- 21.15. ElectroCore LLC
- 21.16. BioElectronics Corporation
- 21.17. MED-EL
- 21.18. Set Point Medical
- 21.19. Cefaly Technology
- 21.20. Medtronic plc.
- 21.21. EnteroMedics Inc.
- 21.22. BioWave Corporation
- 21.23. NeuroSigma Inc.
- 22. Assumptions and Acronyms Used
- 23. Research Methodology
Don't Need a Global Report?
save 40%! on Country & Region specific reports
List Of Table
Table 01: Global Market Volume (‘000 Units) Analysis and Opportunity Assessment 2017 to 2026, By Product Type
Table 02: Global Market Value (US$ Mn) Analysis and Opportunity Assessment 2017 to 2026, By Product Type
Table 03: Global Market Value (US$ Mn) Analysis and Opportunity Assessment 2017 to 2026, By End User
Table 04: Global Market Value (US$ Mn) Analysis and Opportunity Assessment 2017 to 2026, By Region
Table 05: North America Market Value (US$ Mn) Analysis 2017 to 2021 and Forecast 2022 to 2026, By Country
Table 06: North America Market Value (US$ Mn) Analysis and Opportunity Assessment 2017 to 2026, By Product Type
Table 07: North America Market Value (US$ Mn) Analysis and Opportunity Assessment 2017 to 2026, By End User
Table 08: Latin America Market Value (US$ Mn) Analysis 2017 to 2021 and Forecast 2022 to 2026, By Country
Table 09: Latin America Market Value (US$ Mn) Analysis and Opportunity Assessment 2017 to 2026, By Product Type
Table 10: Latin America Market Value (US$ Mn) Analysis and Opportunity Assessment 2017 to 2026, By End User
Table 11: Europe Market Value (US$ Mn) Analysis 2017 to 2021 and Forecast 2022 to 2026, By Country
Table 12: Europe Market Value (US$ Mn) Analysis and Opportunity Assessment 2017 to 2026, By Product Type
Table 13: Europe Market Value (US$ Mn) Analysis and Opportunity Assessment 2017 to 2026, By End User
Table 14: South Asia Market Value (US$ Mn) Analysis 2017 to 2021 and Forecast 2022 to 2026, By Country
Table 15: South Asia Market Value (US$ Mn) Analysis and Opportunity Assessment 2017 to 2026, By Product Type
Table 16: South Asia Market Value (US$ Mn) Analysis and Opportunity Assessment 2017 to 2026, By End User
Table 17: East Asia Market Value (US$ Mn) Analysis 2017 to 2021 and Forecast 2022 to 2026, By Country
Table 18: East Asia Market Value (US$ Mn) Analysis and Opportunity Assessment 2017 to 2026, By Product Type
Table 19: East Asia Market Value (US$ Mn) Analysis and Opportunity Assessment 2017 to 2026, By End User
Table 20: Oceania Market Value (US$ Mn) Analysis 2017 to 2021 and Forecast 2022 to 2026, By Country
Table 21: Oceania Market Value (US$ Mn) Analysis and Opportunity Assessment 2017 to 2026, By Product Type
Table 22: Oceania Market Value (US$ Mn) Analysis and Opportunity Assessment 2017 to 2026, By End User
Table 23: Middle East and Africa Market Value (US$ Mn) Analysis 2017 to 2021 and Forecast 2022 to 2026, By Country
Table 24: Middle East and Africa Market Value (US$ Mn) Analysis and Opportunity Assessment 2017 to 2026, By Product Type
Table 25: Middle East and Africa Market Value (US$ Mn) Analysis and Opportunity Assessment 2017 to 2026, By End User
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
List Of Figures
Figure 01: Global Market Volume (in 000' Units) Analysis, 2017 to 2021
Figure 02: Global Market Volume Forecast (in 000' Units), 2022 to 2026
Figure 03: Pricing Analysis (US$) Per Product Type, By Region, 2021
Figure 04: Pricing Analysis (US$) Per Product Type, By Region, 2021
Figure 05: Global Market Value Analysis (US$ Mn), 2017 to 2021
Figure 06: Global Market Value Forecast (US$ Mn), 2022 to 2026
Figure 07: Global Market Absolute $ Opportunity, 2022 to 2026
Figure 08: Global Market Share Analysis (%), By Product Type, 2022 to 2026
Figure 09: Global Market Y-o-Y Analysis (%), By Product Type, 2022 to 2026
Figure 10: Global Market Attractiveness Analysis by Product Type, 2022 to 2026
Figure 11: Global Market Share Analysis (%), By End User, 2022 to 2026
Figure 12: Global Market Y-o-Y Analysis (%), By End User, 2022 to 2026
Figure 13: Global Market Attractiveness Analysis by End User, 2022 to 2026
Figure 14: Global Market Share Analysis (%), By Region, 2022 to 2026
Figure 15: Global Market Y-o-Y Analysis (%), By Region, 2022 to 2026
Figure 16: Global Market Attractiveness Analysis by Region, 2022 to 2026
Figure 17: North America Market Value Share, By Product Type, 2022 (E)
Figure 18: North America Market Value Share, By End User, 2022 (E)
Figure 19: North America Market Value Share, By Country, 2022 (E)
Figure 20: North America Market Value Analysis (US$ Mn), 2017 to 2021
Figure 21: North America Market Value Forecast (US$ Mn), 2022 to 2026
Figure 22: North America Market Attractiveness Analysis by Product Type, 2022 to 2026
Figure 23: North America Market Attractiveness Analysis by End User, 2022 to 2026
Figure 24: North America Market Attractiveness Analysis by Country, 2022 to 2026
Figure 25: Latin America Market Value Share, By Product Type, 2022 (E)
Figure 26: Latin America Market Value Share, By End User, 2022 (E)
Figure 27: Latin America Market Value Share, By Country, 2022 (E)
Figure 28: Latin America Market Value Analysis (US$ Mn), 2017 to 2021
Figure 29: Latin America Market Value Forecast (US$ Mn), 2022 to 2026
Figure 30: Latin America Market Attractiveness Analysis by Product Type, 2022 to 2026
Figure 31: Latin America Market Attractiveness Analysis by End User, 2022 to 2026
Figure 32: Latin America Market Attractiveness Analysis by Country, 2022 to 2026
Figure 33: Europe Market Value Share, By Product Type, 2022 (E)
Figure 34: Europe Market Value Share, By End User, 2022 (E)
Figure 35: Europe Market Value Share, By Country, 2022 (E)
Figure 36: Europe Market Value Analysis (US$ Mn), 2017 to 2021
Figure 37: Europe Market Value Forecast (US$ Mn), 2022 to 2026
Figure 38: Europe Market Attractiveness Analysis by Product Type, 2022 to 2026
Figure 39: Europe Market Attractiveness Analysis by End User, 2022 to 2026
Figure 40: Europe Market Attractiveness Analysis by Country, 2022 to 2026
Figure 41: South Asia Market Value Share, By Product Type, 2022 (E)
Figure 42: South Asia Market Value Share, By End User, 2022 (E)
Figure 43: South Asia Market Value Share, By Country, 2022 (E)
Figure 44: South Asia Market Value Analysis (US$ Mn), 2017 to 2021
Figure 45: South Asia Market Value Forecast (US$ Mn), 2022 to 2026
Figure 46: South Asia Market Attractiveness Analysis by Product Type, 2022 to 2026
Figure 47: South Asia Market Attractiveness Analysis by End User, 2022 to 2026
Figure 48: South Asia Market Attractiveness Analysis by Country, 2022 to 2026
Figure 49: East Asia Market Value Share, By Product Type, 2022 (E)
Figure 50: East Asia Market Value Share, By End User, 2022 (E)
Figure 51: East Asia Market Value Share, By Country, 2022 (E)
Figure 52: East Asia Market Value Analysis (US$ Mn), 2017 to 2021
Figure 53: East Asia Market Value Forecast (US$ Mn), 2022 to 2026
Figure 54: East Asia Market Attractiveness Analysis by Product Type, 2022 to 2026
Figure 55: East Asia Market Attractiveness Analysis by End User, 2022 to 2026
Figure 56: East Asia Market Attractiveness Analysis by Country, 2022 to 2026
Figure 57: Oceania Market Value Share, By Product Type, 2022 (E)
Figure 58: Oceania Market Value Share, By End User, 2022 (E)
Figure 59: Oceania Market Value Share, By Country, 2022 (E)
Figure 60: Oceania Market Value Analysis (US$ Mn), 2017 to 2021
Figure 61: Oceania Market Value Forecast (US$ Mn), 2022 to 2026
Figure 62: Oceania Market Attractiveness Analysis by Product Type, 2022 to 2026
Figure 63: Oceania Market Attractiveness Analysis by End User, 2022 to 2026
Figure 64: Oceania Market Attractiveness Analysis by Country, 2022 to 2026
Figure 65: Middle East and Africa Market Value Share, By Product Type, 2022 (E)
Figure 66: Middle East and Africa Market Value Share, By End User, 2022 (E)
Figure 67: Middle East and Africa Market Value Share, By Country, 2022 (E)
Figure 68: Middle East and Africa Market Value Analysis (US$ Mn), 2017 to 2021
Figure 69: Middle East and Africa Market Value Forecast (US$ Mn), 2022 to 2026
Figure 70: Middle East and Africa Market Attractiveness Analysis by Product Type, 2022 to 2026
Figure 71: Middle East and Africa Market Attractiveness Analysis by End User, 2022 to 2026
Figure 72: Middle East and Africa Market Attractiveness Analysis by Country, 2022 to 2026
Figure 73: U. S. Market Value Analysis (US$ Mn), 2022 & 2026
Figure 74: U. S. Market Value Share, By Product Type, 2022 (E)
Figure 75: U. S. Market Value Share, By End User, 2022 (E)
Figure 76: Canada Market Value Analysis (US$ Mn), 2022 & 2026
Figure 77: Canada Market Value Share, By Product Type, 2022 (E)
Figure 78: Canada Market Value Share, By End User, 2022 (E)
Figure 79: Mexico Market Value Analysis (US$ Mn), 2022 & 2026
Figure 80: Mexico Market Value Share, By Product Type, 2022 (E)
Figure 81: Mexico Market Value Share, By End User, 2022 (E)
Figure 82: Brazil Market Value Analysis (US$ Mn), 2022 & 2026
Figure 83: Brazil Market Value Share, By Product Type, 2022 (E)
Figure 84: Brazil Market Value Share, By End User, 2022 (E)
Figure 85: U. K. Market Value Analysis (US$ Mn), 2022 & 2026
Figure 86: U. K. Market Value Share, By Product Type, 2022 (E)
Figure 87: U. K. Market Value Share, By End User, 2022 (E)
Figure 88: Germany Market Value Analysis (US$ Mn), 2022 & 2026
Figure 89: Germany Market Value Share, By Product Type, 2022 (E)
Figure 90: Germany Market Value Share, By End User, 2022 (E)
Figure 91: France Market Value Analysis (US$ Mn), 2022 & 2026
Figure 92: France Market Value Share, By Product Type, 2022 (E)
Figure 93: France Market Value Share, By End User, 2022 (E)
Figure 94: Italy Market Value Analysis (US$ Mn), 2022 & 2026
Figure 95: Italy Market Value Share, By Product Type, 2022 (E)
Figure 96: Italy Market Value Share, By End User, 2022 (E)
Figure 97: Spain Market Value Analysis (US$ Mn), 2022 & 2026
Figure 98: Spain Market Value Share, By Product Type, 2022 (E)
Figure 99: Spain Market Value Share, By End User, 2022 (E)
Figure 100: Russia Market Value Analysis (US$ Mn), 2022 & 2026
Figure 101: Russia Market Value Share, By Product Type, 2022 (E)
Figure 102: Russia Market Value Share, By End User, 2022 (E)
Figure 103: China Market Value Analysis (US$ Mn), 2022 & 2026
Figure 104: China Market Value Share, By Product Type, 2022 (E)
Figure 105: China Market Value Share, By End User, 2022 (E)
Figure 106: Japan Market Value Analysis (US$ Mn), 2022 & 2026
Figure 107: Japan Market Value Share, By Product Type, 2022 (E)
Figure 108: Japan Market Value Share, By End User, 2022 (E)
Figure 109: South Korea Market Value Analysis (US$ Mn), 2022 & 2026
Figure 110: South Korea Market Value Share, By Product Type, 2022 (E)
Figure 111: South Korea Market Value Share, By End User, 2022 (E)
Figure 112: India Market Value Analysis (US$ Mn), 2022 & 2026
Figure 113: India Market Value Share, By Product Type, 2022 (E)
Figure 114: India Market Value Share, By End User, 2022 (E)
Figure 115: ASEAN Market Value Analysis (US$ Mn), 2022 & 2026
Figure 116: ASEAN Market Value Share, By Product Type, 2022 (E)
Figure 117: ASEAN Market Value Share, By End User, 2022 (E)
Figure 118: Australia Market Value Analysis (US$ Mn), 2022 & 2026
Figure 119: Australia Market Value Share, By Product Type, 2022 (E)
Figure 120: Australia Market Value Share, By End User, 2022 (E)
Figure 121: New Zealand Market Value Analysis (US$ Mn), 2022 & 2026
Figure 122: New Zealand Market Value Share, By Product Type, 2022 (E)
Figure 123: New Zealand Market Value Share, By End User, 2022 (E)
Figure 124: GCC Countries Market Value Analysis (US$ Mn), 2022 & 2026
Figure 125: GCC Countries Market Value Share, By Product Type, 2022 (E)
Figure 126: GCC Countries Market Value Share, By End User, 2022 (E)
Figure 127: Turkey Market Value Analysis (US$ Mn), 2022 & 2026
Figure 128: Turkey Market Value Share, By Product Type, 2022 (E)
Figure 129: Turkey Market Value Share, By End User, 2022 (E)
Figure 130: South Africa Market Value Analysis (US$ Mn), 2022 & 2026
Figure 131: South Africa Market Value Share, By Product Type, 2022 (E)
Figure 132: South Africa Market Value Share, By End User, 2022 (E)
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
- FAQs -
What is the electroceuticals / bioelectric medicine market value?
The global electroceuticals / bioelectric medicine market is valued at US$ 24.5 billion.
What is the predicted market size for 2026?
Revenue from sales of electroceuticals / bioelectric medicines is estimated to reach US$ 32.1 billion by 2026.
How will demand for electroceuticals / bioelectric medicines evolve in the future?
The electroceuticals / bioelectric medicine market is set to expand at 6.9% CAGR.
Which key market players are profiled in this research study?
Second Sight Medical Products Inc., Oticon Medical, Boston Scientific Corporation, St. Jude Medical, GiMer Medical, Cochlear Limited, ElectroCore LLC, BioElectronics Corporation, MED-EL, Set Point Medical, Cefaly Technology, Medtronic plc., EnteroMedics
What market share is held by North America?
The North America electroceuticals / bioelectric medicine market holds 30% share in the global market.
Electroceuticals / Bioelectric Medicine Market